Trinity Biotech Gets Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
Portfolio Pulse from Benzinga Newsdesk
Trinity Biotech has received a non-compliance notice from Nasdaq regarding its minimum bid price requirement. The company has until March 6, 2024, to regain compliance.

September 11, 2023 | 8:51 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Trinity Biotech has received a non-compliance notice from Nasdaq. The company has until March 6, 2024, to regain compliance with the minimum bid price requirement.
The non-compliance notice from Nasdaq is a significant regulatory issue for Trinity Biotech. Failure to meet the minimum bid price requirement could lead to delisting, which would negatively impact the company's stock price. The company has a period until March 6, 2024, to regain compliance, which adds a level of uncertainty and potential downward pressure on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100